MOXIE significantly reduces cardiovascular events in high-risk chronic disease patients

Researchers from the University of Calgary, the Interdisciplinary Chronic Disease Collaboration (ICDC), and social impact creative agency Emergence Creative are announcing dramatic results that demonstrate a significant improvement in cardiovascular outcomes among patients who received access to a novel educational and support intervention called MOXIE.

Minimally invasive valve repair improves quality of life in patients with tricuspid regurgitation

In patients with a poorly functioning tricuspid valve in the heart, a minimally invasive procedure using a clip to repair the valve was safe and improved both the valve’s functioning and patients’ quality of life at one year compared with the best available medical therapy but did not show any significant difference in survival or heart failure hospitalization, according to research presented at the American College of Cardiology’s Annual Scientific Session Together With the World Congress of Cardiology.

On days when college students feel more impulsive than usual, their alcohol consumption may rise

Fluctuating impulsivity in college students is linked to increased positive thoughts about alcohol, heavier drinking, and more negative consequences, a new study suggests—information that could inform more effective intervention programs to reduce alcohol harm. Almost a third of young adults report binge drinking in the past month, and 16% meet criteria for alcohol use disorder in the past year.

High-dose anticoagulation can reduce intubations and improve survival for hospitalized COVID-19 patients

High-dose anticoagulation can reduce deaths by 30 percent and intubations by 25 percent in hospitalized COVID-19 patients who are not critically ill when compared to the standard treatment, which is low-dose anticoagulation. These are the significant findings from the large-scale international “FREEDOM” trial, led by Valentin Fuster, MD, Ph.D., President of Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital, and General Director of the Spanish National Center for Cardiovascular Research (CNIC).

Researchers discover link between PSA level at time of salvage therapy following surgery and risk of death

The performance characteristics of prostate-specific membrane antigen positron emission tomography improves with increasing prostate-specific antigen (PSA) level. This, coupled with insurance approval concerns if applied for too early, causes some physicians to delay post-radical prostatectomy salvage radiation therapy (sRT) until well after PSA failure, typically at PSA levels exceeding 0.30 ng/ml.